Quantcast
 
Annual return of 118.79% - See How  Click here now!


 

Zacks Upgrades and Revisions Strategy highlights: Amedisys, Atlantic Tele-Network, Bruker and Crown Holdings

Mon. September 15, 2008; Posted: 03:09 PM
Stocks RSS
CHICAGO, Sep 15, 2008 (BUSINESS WIRE) -- CCK | Quote | Chart | News | PowerRating -- Earnings estimate revisions are the most powerful force impacting stock prices. Couple that with the proven benefits of upgrades in ratings from brokerage firms and you have a strategy that delivered a +23.3 return in 2006. Four stocks meeting this screen's exclusive criteria are: Amedisys Inc. (NASDAQ: AMED), Atlantic Tele-Network Inc. (NASDAQ: ATNI), Bruker Corporation (NASDAQ: BRKR | Quote | Chart | News | PowerRating) and Crown Holdings Inc. (NYSE: CCK). View the entire list of stocks for the Upgrades and Revisions Profit Track at http://at.zacks.com/?id=1844.

Here are details on four companies currently identified by the Upgrades and Revisions Profit Track:

Amedisys Inc. (NASDAQ: AMED), a Zacks #1 Rank company, earned its place on this profit track with five-year historical EPS growth of 35.16% and an EPS surprise of 11.76%. In the second quarter, AMED's year-over-year net earnings increased to 76 cents per share from 57 cents, while analysts expected earnings of 68 cents. AMED is a leading multi-regional provider of home health care nursing services.

Atlantic Tele-Network Inc. (NASDAQ: ATNI | Quote | Chart | News | PowerRating) is a telecommunications company that qualifies for this profit track with historical EPS growth of 24.07% over the past five years, a Zacks #1 Rank, and a recent EPS surprise of 24.07%. The screen calls for five-year historical EPS growth greater than 17% and an EPS surprise of greater than 10% in its most recent quarter. ATNI's fiscal second-quarter EPS amounted to 67 cents, compared to 53 cents a year earlier.

Bruker Corporation (NASDAQ: BRKR | Quote | Chart | News | PowerRating) operates in two segments: the life science and analytical systems segment, and the international advanced superconductor segment. The Zacks #2 Rank company reported outstanding second-quarter results of 13 cents per share, marking an EPS surprise of 44.4%. BRKR satisfies this screen's parameters with a per share price of $15.99 and a historical EPS growth rate 72.79% over the past five years.

Crown Holdings Inc. (NYSE: CCK | Quote | Chart | News | PowerRating) enjoys a five-year historical EPS growth rate of 42.25% and a Zacks #2 Rank. For the second quarter, the company reported earnings of 61 cents per share, which exceeded the consensus of 55 cents. CCK is a leading supplier of packaging products to consumer marketing companies around the world.

Discover all the current stocks currently on the Upgrades and Revisions Profit Track at: http://at.zacks.com/?id=1869

About Profit Tracks

What is a "Profit Track"? Each Profit Track is a successful stock picking strategy with proven results through the Bear Market of 2001-2002 and the Bull run started in 2003. On Zacks.com we have created these nine unique screens to offer investors great strategies to potentially outperform the market in the years ahead. In 2006, the Low Price Stocks strategy was the top performing Profit Track with a return of +56.5% followed by the Discounted Fundamental screen with a +34% return. To see all nine strategies along with philosophy, past performance and current stocks, go to http://at.zacks.com/?id=1838.

All the Profit Track strategies were created and backtested using the Research Wizard software from Zacks Investment Research. If you like this screening strategy, but want to narrow down the list of stocks and even improve the performance, then you should start a free trial to this powerful stock picking tool. Learn more about the Research Wizard free trial offer and our new special report "Top 10 Stock Screening Strategies" at http://at.zacks.com/?id=4616.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at http://at.zacks.com/?id=4617.

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

SOURCE: Zacks.com

Zacks.com Alla Kushner Phone: 312-265-9208 Email: pr@zacks.com Visit: www.Zacks.com

For full details on Amedisys Inc (AMED) click here. Amedisys Inc (AMED) has Short Term PowerRatings of 6. Details on Amedisys Inc (AMED) Short Term PowerRatings is available at This Link.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [AMED]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.